<DOC>
	<DOCNO>NCT00148720</DOCNO>
	<brief_summary>The purpose study find effect ( good bad ) take capecitabine 12 week surgery woman breast cancer .</brief_summary>
	<brief_title>Capecitabine Women With Operable Breast Cancer</brief_title>
	<detailed_description>- Prior start treatment , patient small metal clip insert tumor bed identify tumor site surgeon . At time , needle biopsy breast tumor sentinel ( underarm ) lymph node biopsy also perform . - Patients take capecitabine orally twice daily 14 day . This treatment repeat every 21 day ( 1 cycle ) . Patients receive 4 cycle treatment . - A physical exam blood work do every three week start therapy monitor side effect . - After two week capecitabine biopsy tumor do generate information characteristic tumor may respond capecitabine . - After complete 4 cycle ( 12 week ) capecitabine , patient undergo surgery remove remain breast cancer ( lumpectomy mastectomy ) . Post-surgical treatment ( radiation , chemotherapy , hormonal therapy ) discretion patient physician .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Histological confirmation primary invasive breast cancer Stage IIII operable breast cancer . Primary tumor must great equal 2cm radiographic image palpitation Women great 18 year age ECOG performance status 01 WBC &gt; 4000/mm3 Platelet count &gt; 100,000/mm3 SGOT &lt; 2x ULN Calculated creatinine clearance &gt; 50ml/min Evidence metastatic ( stage IV ) cancer physical exam diagnostic study . Pregnant breastfeed woman Inflammatory breast cancer HER2 positive disease History hypersensitivity 5FU know dihydropyrimidine dehydrogenase ( DPD ) deficiency Uncontrolled intercurrent illness Prior history breast cancer ineligible except : diagnose least 2 year ago ; present cancer previously irradiate breast ; prior chemotherapy past 5 year ; prior highdose chemotherapy stem cell bone marrow transplant . Excisional biopsy perform prior enrollment Uncontrolled coagulopathy Lack physical integrity upper gastrointestinal tract malabsorption syndrome .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Invasive Breast Cancer</keyword>
	<keyword>Operable Breast Cancer</keyword>
	<keyword>Capecitabine</keyword>
</DOC>